Cantitate/Preț
Produs
Total produse
Vezi coșul
Progress in Radiopharmacy de August P. Schubiger

Progress in Radiopharmacy: Developments in Nuclear Medicine, cartea 22

Editat de August P. Schubiger, Gerrit Westera
en Limba Engleză Hardback – 31 dec 1991

Din seria Developments in Nuclear Medicine

  • 5% Safety and efficacy of radiopharmaceuticals
    Preț: 36144 lei
  • 5% Cholescintigraphy
    Preț: 37676 lei
  • 5% Progress in Radiopharmacy
    Preț: 307655 lei
  • 5% Principles of Radiopharmacology
    Preț: 104967 lei
  • 5% Clinical efficacy of positron emission tomography: Proceedings of a workshop held in Cologne, FRG, sponsored by the Commission of the European Communities as advised by the Committee on Medical and Public Health Research
    Preț: 36213 lei
  • 5% Age-Related Factors in Radionuclide Metabolism and Dosimetry: Radiation Protection Programme and the Commissariat à l'Energie Atomique, Institut de Protection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
    Preț: 202948 lei
  • 5% Safety and efficacy of radiopharmaceuticals 1987
    Preț: 36270 lei
  • 5% Clinical Application of Radiolabelled Platelets
    Preț: 35839 lei
  • 5% Nuclear Medicine in Gastroenterology
    Preț: 69022 lei
  • 5% Clinical Use of Antibodies: Tumours, infection, infarction, rejection and in the diagnosis of AIDS
    Preț: 68318 lei
  • 5% Brain Dopaminergic Systems: Imaging with Positron Tomography
    Preț: 68387 lei
  • 5% Radioiodination: Theory, Practice, and Biomedical Applications
    Preț: 204774 lei
  • 5% PET Studies on Amino Acid Metabolism and Protein Synthesis: Proceedings of a Workshop held in Lyon, France within the framework of the European Community Medical and Public Health Research
    Preț: 68774 lei
  • 5% Radiopharmaceuticals for Positron Emission Tomography - Methodological Aspects
    Preț: 105476 lei
  • 5% The Clinical Applications of SPET
    Preț: 68793 lei
  • 5% PET for Drug Development and Evaluation
    Preț: 106248 lei
  • 5% Biological Models in Radiopharmaceutical Development
    Preț: 35793 lei
  • 5% Clinical PET
    Preț: 68090 lei
  • 5% SPECT Imaging of the Brain
    Preț: 105231 lei
  • 5% X-ray fluorescent scanning of the thyroid
    Preț: 35203 lei
  • 5% Current Directions in Radiopharmaceutical Research and Development
    Preț: 105549 lei
  • 5% The Imaging of Infection and Inflammation
    Preț: 105564 lei
  • 5% The Theory and Practice of 3D PET
    Preț: 105737 lei
  • 5% Imaging of Hypoxia: Tracer Developments
    Preț: 105355 lei
  • 5% Nuclear Medicine in Tropical and Infectious Diseases
    Preț: 68741 lei
  • 5% Amplitude/phase patterns in dynamic scintigraphic imaging
    Preț: 35042 lei
  • 5% Blood cells in nuclear medicine, part I
    Preț: 36542 lei
  • 5% Blood cells in nuclear medicine, part II
    Preț: 36927 lei
  • 5% Radioisotope studies in cardiology
    Preț: 36430 lei
  • 5% Progress in Radiopharmacology 1985
    Preț: 35793 lei

Preț: 135925 lei

Preț vechi: 143079 lei
-5%

Puncte Express: 2039
Paperback 135240 lei
Hardback 135925 lei

Carte tipărită la comandă

Livrare economică 15-29 iulie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă

Specificații

ISBN-13: 9780792315254
ISBN-10: 0792315251
Pagini: 228
Ilustrații: XIII, 228 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.53 kg
Ediția:1992
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

1. Future development of radiopharmaceuticals.- One: Brain receptor ligands.- 2. Necessary conditions for a multicenter study with a new radiopharmaceutical. Example: 123 I-Iomazenil.- 3. Design and evaluation of new receptor ligands exemplified by recent developments in the pharmacology of the benzodiazepine receptor.- 4. Studies on substituted benzamides as brain dopamine receptor imaging agent.- Two: Technetium-99m and other radionuclide generators.- 5. Cell labeling in radiopharmacy: what can radiolabeled monoclonal antibodies offer?.- 6. Automated systems for the preparation of Tc-kits in hospitals.- 7. New radiopharmaceuticals based on Technetium.- 8. The development of new radionuclide generator systems for nuclear medicine applications.- Three: Positron Emission Tomography.- 9. Production and application of oxygen-15; radiopharmacy aspects.- 10. Clinical aspects of positron emission tomography.- 11. Carbon-11 radiopharmaceuticass - radiopharmacy aspects.- 12. Production and distribution of 18F-radiopharmaceuticals - 2-deoxy-2[18F]fluoro-D-Glucose — radiopharmaceutic aspects.- 13. Preclinical data necessary to assess PET examinations.- Four: Rules and regulations.- 14. EEC directives and radiopharmaceuticals: the point of view of the radiopharmaceutical industry.- 15. European regulations and guidelines for the registration of radiopharmaceuticals.- 16. General guidelines for the quality assurance and quality control of short-lived radiopharmaceuticals.- 17. Legal and regulatory aspects of PET radiopharmaceuticals in the USA.- Five: Education.- 18. The development of a co-ordinated training programme in radiopharmacy in Europe.- 19. Experiences in postgraduate education of radiochemists and radiopharmacists at Berlin- Buch.- Six: Appendix.- 20. Monoclonalchimeric antibodies to HIV-1 - Clinical perspectives.- 21. Tracer technique - the Swiss story.

Recenzii

'...results in a publication that should serve as a useful resource for radioharmacists, radiopharmaceutical scientists, and nuclear medicine clinicians working in academic and research environments.' Clinical Nuclear Medicine Sep. 1992